publicações selecionadas
-
artigo académico
- Plasma cell leukaemia. Porto Biomedical Journal. 2016
- Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. British Journal of Haematology. 2012
-
artigo de revista
- Biometrics and quality of life of lymphoma patients: A longitudinal mixed-model approach. Electronics. 2021
- Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma. Cellular Oncology. 2019
- Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients. British Journal of Haematology. 2018
- Identification of miRSNPs associated with the risk of multiple myeloma. International Journal of Cancer. 2017
- Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability. International Journal of Molecular Epidemiology and Genetics. 2016
- A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis. Oncotarget. 2016
- Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.. Tumor Biology. 2015
- Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.. Endocrine-Related Cancer. 2015
- Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature Communications. 2015
- Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.. International Journal of Cancer. 2014
- Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.. Cancer Epidemiology Biomarkers & Prevention. 2014
- Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. Journal of Human Genetics. 2013
- Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. British Journal of Haematology. 2012
- Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis. Oncology Letters. 2012
- Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).. International Journal of Oncology. 2012
- The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes and Immunity. 2012
-
documento
-
teses